01
Cash & equivalents decreased 34.5%
Cash & equivalents changed -34.5% from the comparable as-filed period.
$19.7M→$12.9MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTDesign Therapeutics, Inc.'s latest supported as-filed period reports revenue of $0. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -34.5% from the comparable as-filed period.
Net income changed -5.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating income changed -2.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
DSGN · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-329579SEC ↗8-KAug 3, 2026Period Aug 3, 20260001193125-26-329570SEC ↗4Jun 11, 2026Period Jun 9, 20260001193125-26-267732SEC ↗4Jun 11, 2026Period Jun 9, 20260001478916-26-000009SEC ↗4Jun 11, 2026Period Jun 9, 20260001579826-26-000002SEC ↗4Jun 11, 2026Period Jun 9, 20260001754129-26-000006SEC ↗4Jun 11, 2026Period Jun 9, 20260001559570-26-000008SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jun 9, 2026Filed Jun 11, 2026 | George SimeonDirector | Grant Or AwardDirect | 30,000 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed +4.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed -3.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001751873-26-000002